Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone

被引:11
作者
Bharara, T. [1 ]
Bhalla, P. [1 ]
Rawat, D. [1 ]
Garg, V. K. [2 ]
Sardana, K. [2 ]
Chakravarti, A. [1 ]
机构
[1] Maulana Azad Med Coll, Dept Microbiol, New Delhi, India
[2] Maulana Azad Med Coll, Dept Dermatol & Sexually Transmitted Dis, New Delhi, India
关键词
Antimicrobial susceptibility; gonococcal antimicrobial surveillance program; Neisseria gonorrhoeae; penicillinase producing N. gonorrhoeae; quinolone-resistant N. gonorrhoeae; NEW-DELHI; INDIA; CEFIXIME; WORLD; ASIA;
D O I
10.4103/0255-0857.148374
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Context: Gonorrhoea is one of the most common sexually transmitted infections (STI) in developing countries and is a global health problem. Aims: To analyze the trend of antimicrobial susceptibility of Neisseria gonorrhoeae isolates over the years, in a tertiary care hospital of North India. Settings and Design: The study population comprised males with urethritis and females with endocervicitis attending STI clinic of our hospital. Materials and Methods: In our STI laboratory, all gonococcal isolates are subjected to antimicrobial susceptibility testing by disc diffusion method as per CLSI guidelines. beta-lactamase production is determined by chromogenic cephalosporin test. Minimum Inhibitory Concentration (MIC) for ceftriaxone is determined by E-test. Statistical Analysis Used: Data were expressed as percentages. The differences in percentages were tested for statistical significance by using chi(2) test and P values were determined. Results: The percentage of penicillinase producing N. gonorrhoeae (PPNG) increased from 8% in 1995-96 to 20% in 2004-05 and 88% in 2011-2013. Quinolone-resistant N. gonorrhoeae (QRNG) showed a significant increase from 12% in 1995-96 to 98.3% in 2004-05, while 84% isolates were found to be QRNG by 2011-2013. In January 2013 we detected our first gonococcal isolate with decreased susceptibility to third-generation cephalosporins; Ceftriaxone, Cefixime and Cefpodoxime (MIC for ceftriaxone = 0.19 mu g/ml). Conclusions: The results of our study highlighted an alarming increase in the percentage of PPNG and QRNG strains over the years. Emergence of N. gonorrhoeae isolates with decreased susceptibility to third-generation cephalosporins is a cause of concern and thus emphasises the importance of antimicrobial susceptibility testing.
引用
收藏
页码:39 / 42
页数:4
相关论文
共 17 条
[1]  
[Anonymous], 2012, Sexually transmitted disease surveillance
[2]  
[Anonymous], 2003, COMMUN DIS INTELL, V27, P488
[3]   First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India [J].
Bala, M ;
Ray, K ;
Salhan, S .
SEXUALLY TRANSMITTED INFECTIONS, 2005, 81 (02) :186-187
[4]   Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis [J].
Bala, Manju ;
Kakran, Monika ;
Singh, Vikram ;
Sood, Seema ;
Ramesh, V. .
SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 (04) :28-35
[5]   Antimicrobial susceptibility and plasmid profile of Neisseria gonorrhoeae in India (New delhi) [J].
Bhalla, P ;
Sethi, K ;
Reddy, BSN ;
Mathur, MD .
SEXUALLY TRANSMITTED INFECTIONS, 1998, 74 (03) :210-212
[6]   Trust and the regulation of pharmaceuticals: South Asia in a globalised world [J].
Brhlikova, Petra ;
Harper, Ian ;
Jeffery, Roger ;
Rawal, Nabin ;
Subedi, Madhusudhan ;
Santhosh, M. R. .
GLOBALIZATION AND HEALTH, 2011, 7
[7]   Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain [J].
Camara, Jordi ;
Serra, Judit ;
Ayats, Josefina ;
Bastida, Teresa ;
Carnicer-Pont, Dolors ;
Andreu, Antonia ;
Ardanuy, Carmen .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) :1858-1860
[8]  
Clinical and Laboratory Standards Institute (CLSI), 2011, M100S21 CLSI S, V31, P92
[9]  
Khaki P, 2007, Indian J Med Microbiol, V25, P225
[10]  
Laboratory Diagnosis of Gonorrhoea, 1999, WHO REG PUBL S E AS, V33